company background image
540701 logo

Dishman Carbogen Amcis BSE:540701 Stock Report

Last Price

₹190.25

Market Cap

₹29.1b

7D

1.2%

1Y

18.1%

Updated

12 Nov, 2024

Data

Company Financials

Dishman Carbogen Amcis Limited

BSE:540701 Stock Report

Market Cap: ₹29.1b

540701 Stock Overview

Provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide.

540701 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Rewards

Risk Analysis


Dishman Carbogen Amcis Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dishman Carbogen Amcis
Historical stock prices
Current Share Price₹190.25
52 Week High₹282.95
52 Week Low₹132.75
Beta1.24
11 Month Change3.96%
3 Month Change10.71%
1 Year Change18.09%
33 Year Change-15.44%
5 Year Change52.63%
Change since IPO-45.84%

Recent News & Updates

Recent updates

Shareholder Returns

540701IN Life SciencesIN Market
7D1.2%0.1%0.1%
1Y18.1%56.2%33.4%

Return vs Industry: 540701 underperformed the Indian Life Sciences industry which returned 56.2% over the past year.

Return vs Market: 540701 underperformed the Indian Market which returned 33.4% over the past year.

Price Volatility

Is 540701's price volatile compared to industry and market?
540701 volatility
540701 Average Weekly Movement7.5%
Life Sciences Industry Average Movement6.5%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market3.9%

Stable Share Price: 540701 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 540701's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19831,132Arpit Vyasimdcal.com

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables.

Dishman Carbogen Amcis Limited Fundamentals Summary

How do Dishman Carbogen Amcis's earnings and revenue compare to its market cap?
540701 fundamental statistics
Market cap₹29.12b
Earnings (TTM)-₹2.48b
Revenue (TTM)₹24.16b

1.2x

P/S Ratio

-12.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
540701 income statement (TTM)
Revenue₹24.16b
Cost of Revenue₹5.05b
Gross Profit₹19.11b
Other Expenses₹21.59b
Earnings-₹2.48b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 13, 2024

Earnings per share (EPS)-15.82
Gross Margin79.10%
Net Profit Margin-10.27%
Debt/Equity Ratio41.1%

How did 540701 perform over the long term?

See historical performance and comparison